Q4/2024 12/31/2024 EPS 0.150 ZacksConsensus 0.080 ActVsEst 0.070 - Beat
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple SclerosisGlobeNewswire
- TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumGlobeNewswire
- Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics (NASDAQ:TGTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $49.00 to $46.00. They now have an "overweight" rating on the stock.MarketBeat
TGTX
Earnings
- 11/3/25 - Beat
TGTX
Sec Filings
- 1/29/26 - Form 4
- 1/13/26 - Form 8-K
- 1/9/26 - Form 4
- TGTX's page on the SEC website